Drugs / RU-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01843894 | Apr 2013 → Jul 2014 | dry eye syndrome | R-Tech Ueno, Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RU-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01843894 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant human serum albumin” NCT01843894 ↗ |
| Route | Topical | “instilled 6 times daily into each eye” NCT01843894 ↗ |